“Pharmaceutical care directed to patients with rheumatoid arthritis and systemic lupus erythematosus: survey of a pharmacotherapeutic profile”, RSD, vol. 11, no. 16, p. e203111638026, Dec. 2022, doi: 10.33448/rsd-v11i16.38026.